gorodenkoff/iStock via Getty Images Evotec SE (NASDAQ:EVO) ADRs surged 20% in premarket trading after a report that Triton Partners is considering a takeover offer for the German drug developer. The ...
Source Linkgorodenkoff/iStock via Getty Images Evotec SE (NASDAQ:EVO) ADRs surged 20% in premarket trading after a report that Triton Partners is considering a takeover offer for the German drug developer. The ...
Source Link
Comments